MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Oligosymptomatic Fahr’s syndrome (2 clinical cases)

Y. Solodovnikova (Odessa, Ukraine)

Meeting: 2018 International Congress

Abstract Number: 474

Keywords: Venlafaxine

Session Information

Date: Saturday, October 6, 2018

Session Title: Rare Genetic and Metabolic Diseases

Session Time: 1:45pm-3:15pm

Location: Hall 3FG

Objective: Two clinical cases of Fahr`s syndrome was presented.

Background: Fahr’s syndrome (FS) or secondary bilateral striatopallidodentate calcinosis is a rare neurological disorder characterized by bilateral symmetrical calcification of basal ganglia, cerebellar subcortical white matter, hippocampus and thalamus. It included a variety of neurological and psychiatric disturbances. FS is mostly associated with endocrinopathies, but can also be attributed to other etiologies such as infections, brain neoplasms or previous brain injury.

Methods: A 34 year old woman presented to the Neurological Department of the Odessa National Medical University Clinic with headache, painful muscle contraction of the limbs, depressed mood, anxiety, irregular sleep-wake syndrome. There is 5-year history of hypoparathyroidism and hypothyroidism is preceding. Neurological examination shows moderate bradykinetic Parkinsonian syndrome. CT revealed extensive bilateral symmetrical calcification of basal ganglia [figure1]. Patient improved with therapeutic doses of amantadine, venlafaxine and benzodiazepine.

Results: A 21-year-old woman complained about headache, anxiety, sleep disturbances. In the neurological status without pathology. CT of the brain: insignificant bilateral symmetrical calcification along both medial cerebral arteries and both cerebellum hemispheres. Patient improved with venlafaxine and benzo.

Conclusions: FS is a very rare disease and the pathophysiological mechanism of calcium deposits in extracellular and perivascular zones is unknown. Clinical picture could be poor with the prevalence of extrapyramidal or general symptoms. CT is the preferred method of determining the localization of lesions.

To cite this abstract in AMA style:

Y. Solodovnikova. Oligosymptomatic Fahr’s syndrome (2 clinical cases) [abstract]. Mov Disord. 2018; 33 (suppl 2). https://www.mdsabstracts.org/abstract/oligosymptomatic-fahrs-syndrome-2-clinical-cases/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/oligosymptomatic-fahrs-syndrome-2-clinical-cases/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley